This was a 68-week study of 445 adults with obesity or overweight who also had knee osteoarthritis
Presented for research literature review only Gras C et al
CivantosEThuillerWMaioranoLGuisanAArajoMB
If CagriSema truly prevents the metabolic slowdown associated with weight loss, as the preclinical data suggests, it could produce more durable outcomes with less weight regain after treatment completion
If youre considering semaglutide for medical weight loss, consult with our specialists today and take the first step toward a healthier, more confident you
The choice between these medications requires a thoughtful evaluation of individual needs, priorities, and treatment goals, underscoring the importance of personalized medicine in navigating the landscape of GLP-1 receptor agonists